Smith & Nephew (SNN) stock
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on SNN
| The company | Profit up 52% to $625M |
| Latest filing | 6-K, Oct 1 |
SNN in the news
Big story
Smith+Nephew cuts outlook after failed orthopaedics deal talks with J&J
SNN closed +7.6% that day on 1.7x normal volume.
SNN catalysts
After its last 2 reports it closed -4.2% on average, higher 0 of 2 times.
Why SNN scores 2
Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
- +2Chart checks 2 of 14 firing right now, one point each
- −3News guidance cut
- Size adds
- Profit adds
How SNN ranks in Medical Devices
SNN is #61 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 61 |
When does SNN report earnings, and what happens after?
Reports Mon Mar 1, before the open (in 111 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Close after the report, last 2
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Aug 4, 2026 | -4.3% | -5.3% | -6.4% |
| Mar 2, 2026 | -4.1% | -3.1% | -7.0% |
SNN has 2 of 14 chart checks firing
SNN RSI today: 59.0, above its 50-day, below its 200-day
RSI 59.0, MACD above signal, above its 50-day, below its 200-day. Not scored.
The deep dive on SNN
- What it does and how it makes money
- Where it standsEx-dividend dates and amounts, from the market data vendor
- Who holds and trades it
- Against its closest peers
SNN insider trades
SNN trades by Congress and the executive branch
One trade disclosed in the last six months. The newest:
About Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Pro members see every line of every stock's score.
- What would turn SNN's score around: 4 things
- 7 more filings explained, a plain line each
- Real-time prices, no delay
Straight AnswersStraight Answers
What does SNN's Quality Score say?
SNN scores 2 today, which Breakaway calls Below Average. It is #61 of 84 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is SNN's Quality Score?
SNN scores 2 today, which Breakaway calls Below Average (0 to 5). That is #61 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SNN's 2.
When does SNN report earnings?
Reports Mon Mar 1, before the open, a date the company confirmed. SNN closed higher after 0 of its last 2 reports. Past behavior, not a forecast.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.